Compare TJX & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TJX | ABT |
|---|---|---|
| Founded | 1962 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.0B | 183.3B |
| IPO Year | 1994 | 2006 |
| Metric | TJX | ABT |
|---|---|---|
| Price | $157.19 | $89.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $169.00 | $130.90 |
| AVG Volume (30 Days) | 3.5M | ★ 10.0M |
| Earning Date | 05-20-2026 | 04-16-2026 |
| Dividend Yield | 1.23% | ★ 2.76% |
| EPS Growth | ★ 14.32 | N/A |
| EPS | ★ 4.87 | 0.61 |
| Revenue | $29,078,407,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $6.75 | $10.75 |
| Revenue Next Year | $5.81 | $8.10 |
| P/E Ratio | ★ $32.23 | $148.95 |
| Revenue Growth | ★ 6.04 | 5.67 |
| 52 Week Low | $119.84 | $90.29 |
| 52 Week High | $165.82 | $137.49 |
| Indicator | TJX | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 27.18 |
| Support Level | $156.42 | N/A |
| Resistance Level | $158.36 | $130.24 |
| Average True Range (ATR) | 2.56 | 2.23 |
| MACD | -0.42 | -0.23 |
| Stochastic Oscillator | 32.07 | 4.50 |
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2026, the company generated roughly $60 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.